SIMCERE PHARMAC (Germany) Price Prediction
| S2P Stock | EUR 0.89 0.05 5.95% |
Oversold Vs Overbought
53
Oversold | Overbought |
Using SIMCERE PHARMAC hype-based prediction, you can estimate the value of SIMCERE PHARMAC GRP from the perspective of SIMCERE PHARMAC response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in SIMCERE PHARMAC to buy its stock at a price that has no basis in reality. In that case, they are not buying SIMCERE because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
SIMCERE PHARMAC after-hype prediction price | EUR 0.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
SIMCERE |
SIMCERE PHARMAC After-Hype Price Prediction Density Analysis
As far as predicting the price of SIMCERE PHARMAC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in SIMCERE PHARMAC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of SIMCERE PHARMAC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
SIMCERE PHARMAC Estimiated After-Hype Price Volatility
In the context of predicting SIMCERE PHARMAC's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on SIMCERE PHARMAC's historical news coverage. SIMCERE PHARMAC's after-hype downside and upside margins for the prediction period are 0.04 and 3.85, respectively. We have considered SIMCERE PHARMAC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
SIMCERE PHARMAC is extremely dangerous at this time. Analysis and calculation of next after-hype price of SIMCERE PHARMAC GRP is based on 3 months time horizon.
SIMCERE PHARMAC Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as SIMCERE PHARMAC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SIMCERE PHARMAC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SIMCERE PHARMAC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.44 | 2.96 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.89 | 0.89 | 0.00 |
|
SIMCERE PHARMAC Hype Timeline
SIMCERE PHARMAC GRP is at this time traded for 0.89on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SIMCERE is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.44%. %. The volatility of related hype on SIMCERE PHARMAC is about 0.0%, with the expected price after the next announcement by competition of 0.89. About 69.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 28th of June 2022. Assuming the 90 days horizon the next estimated press release will be within a week. Check out SIMCERE PHARMAC Basic Forecasting Models to cross-verify your projections.SIMCERE PHARMAC Related Hype Analysis
Having access to credible news sources related to SIMCERE PHARMAC's direct competition is more important than ever and may enhance your ability to predict SIMCERE PHARMAC's future price movements. Getting to know how SIMCERE PHARMAC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how SIMCERE PHARMAC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AC8 | ARISTOCRAT LEISURE | 0.00 | 0 per month | 0.12 | 0.29 | 2.07 | (1.12) | 5.10 | |
| RC2 | RCM TECHNOLOGIES | 0.00 | 0 per month | 2.14 | 0.07 | 4.81 | (4.59) | 15.24 | |
| 7E3 | PLAYSTUDIOS A DL 0001 | 0.00 | 0 per month | 2.61 | 0.12 | 6.99 | (4.19) | 13.90 | |
| FDU | Commercial Vehicle Group | 0.00 | 0 per month | 0.00 | (0.16) | 6.06 | (4.83) | 16.76 | |
| A2X | AAC TECHNOLOGHLDGADR | 0.00 | 0 per month | 2.71 | 0.06 | 6.29 | (4.47) | 19.84 | |
| XXA1 | Axcelis Technologies | 0.00 | 0 per month | 0.00 | (0.17) | 3.99 | (4.32) | 12.02 | |
| 1D8 | ACCSYS TECHPLC EO | 0.00 | 0 per month | 0.00 | (0.07) | 3.70 | (3.57) | 10.58 | |
| 688 | PLAY2CHILL SA ZY | 0.00 | 0 per month | 1.64 | 0.02 | 3.53 | (3.41) | 18.94 |
SIMCERE PHARMAC Additional Predictive Modules
Most predictive techniques to examine SIMCERE price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for SIMCERE using various technical indicators. When you analyze SIMCERE charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About SIMCERE PHARMAC Predictive Indicators
The successful prediction of SIMCERE PHARMAC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as SIMCERE PHARMAC GRP, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of SIMCERE PHARMAC based on analysis of SIMCERE PHARMAC hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to SIMCERE PHARMAC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to SIMCERE PHARMAC's related companies.
Story Coverage note for SIMCERE PHARMAC
The number of cover stories for SIMCERE PHARMAC depends on current market conditions and SIMCERE PHARMAC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that SIMCERE PHARMAC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about SIMCERE PHARMAC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
SIMCERE PHARMAC Short Properties
SIMCERE PHARMAC's future price predictability will typically decrease when SIMCERE PHARMAC's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of SIMCERE PHARMAC GRP often depends not only on the future outlook of the potential SIMCERE PHARMAC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SIMCERE PHARMAC's indicators that are reflective of the short sentiment are summarized in the table below.
| Dividend Yield | 0.0182 | |
| Forward Annual Dividend Rate | 0.02 | |
| Shares Float | 814 M |
Complementary Tools for SIMCERE Stock analysis
When running SIMCERE PHARMAC's price analysis, check to measure SIMCERE PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIMCERE PHARMAC is operating at the current time. Most of SIMCERE PHARMAC's value examination focuses on studying past and present price action to predict the probability of SIMCERE PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIMCERE PHARMAC's price. Additionally, you may evaluate how the addition of SIMCERE PHARMAC to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |